Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study (Q84614866)
Jump to navigation
Jump to search
scientific article published on 27 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study |
scientific article published on 27 July 2011 |
Statements
Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study (English)
Daniel J Wallace
Michelle Petri
Kyriakos A Kirou
Yihong Yao
Wendy I White
Gabriel Robbie
Robert Levin
Seth M Berney
Vishala Chindalore
Nancy Olsen
Laura Richman
Chenxiong Le
Bahija Jallal
Barbara White
Lupus Interferon Skin Activity (LISA) Study Investigators